8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Discover what makes Veristat a distinguished name in the life sciences industry. Veristat is a scientific-minded global clinical research organization (CRO) and consultancy that integrates full-service clinical trial execution, regulatory consulting, and strategic planning to accelerate the development, approval, and commercialization of groundbreaking therapies worldwide.
Join us at BIO-Europe Spring 2025, a premier partnering event uniting biotech executives, pharma business teams, investors, and industry experts. The conference will be held from March 17-19, 2025, at the Allianz MiCo Convention Centre in Milan.
Our experienced team looks forward to discussing how Veristat can support your clinical research and regulatory needs in the European market and beyond.
Veristat Attendees:
Lorenzo Scalisse - Business Development Manager
Conference Details:
Date: March 17-19, 2025
Location: Allianz MiCo Convention Centre in Milan
Schedule a Meeting:
Fill out the form to schedule a meeting with Lorenzo to learn how we can help you accelerate your clinical trials, regulatory submissions, and market access strategies.
Learn more about the conference
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...